Hemostasis Products Market to Grow at a CAGR of 4.6% During the Forecast Period 2021-2026 briefingwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from briefingwire.com Daily Mail and Mail on Sunday newspapers.
Tricol Biomedical co-develops cutting-edge convenience kit with Tactical Medical Solutions
The OLAES® Hemostatic Modular Bandage combines the globally recognized OLAES® Modular Bandage with battle-tested HemCon® ChitoGauze® PRO, creating the most comprehensive trauma bandage for multiple injury profiles.
Portland, OR, April 06, 2021 (GLOBE NEWSWIRE) Tricol Biomedical and Tactical Medical Solutions
® have partnered to launch the next generation of the OLAES
® Modular Bandage. By combining the proven battlefield effectiveness of HemCon
® ChitoGauze
® Modular Bandage, the two companies have created a cutting-edge convenience kit – the OLAES
® Hemostatic Modular Bandage. Being highly hemostatic in effect and modular in its flexibility, this is an industry first with the ability to treat multiple injury profiles – all in one package.
Medline Expanding Clinician Access to Products Designed to Safely Control Bleeding
Distribution agreement with Tricol Biomedical aims to increase portfolio reach across North America
News provided by
Share this article
Share this article
NORTHFIELD, Ill., Jan. 6, 2021 /PRNewswire/ Medline and Tricol Biomedical, Inc. today announced an exclusive agreement to distribute Hemostatic Control (HemCon) products in North America to acute care, emergency services, and cath lab providers.
Severe bleeding accounts for over 35% of pre-hospital deaths and close to 40% of deaths within the first 24 hours of sustaining an injury, according to a 2015 National Trauma Institute estimate.
Rapid control of bleeding can be applied across specialties within the continuum of care, from Trauma to Cardiology to Home Health. Managing blood loss within a healthcare facility can prevent unnecessary deaths in severe cases or improve a patient s care experience during vascular access procedures or r